-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Analysis of circulating mitochondrial DNA (cmtDNA) has received attention because of its potential to be a clinically useful indicator of tissue damage and disease burden in several diseases
Analysis of circulating mitochondrial DNA (cmtDNA) has received attention because of its potential to be a clinically useful indicator of tissue damage and disease burden in several diseases
The researchers collected 21 patients who underwent liver transplantation (LT) at Austin Hospital in Melbourne between September 2019 and February 2020
manage
The results of this study found that the incidence of postoperative complications in LT patients was 47.
Figure: Circulating mitochondrial DNA levels and differences in different liver transplant patients
This study demonstrates that early release of plasma cmtDNA is closely related to hepatocyte damage; however, the late surge of cmtDNA in EAD patients does not appear to be associated with hepatocyte damage
This study demonstrates that early release of plasma cmtDNA is closely related to hepatocyte damage; however, the late surge of cmtDNA in EAD patients does not appear to be associated with hepatocyte damage
Osamu Yoshino.
Elevated levels of circulating mitochondrial DNA predict early allograft dysfunction in patients following liver transplantation.
Leave a comment here